DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

228.49 0.25 (0.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $228.49 0.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $228.57
Previous Close $228.24
Daily Range $224.36 - $229.53
52-Week Range $106.00 - $246.01
Market Cap $78.3B
P/E Ratio 77.45
Dividend (Yield) $0.00 (0.0%)
Volume 981,188
Average Daily Volume 1,685,169
Current FY EPS $2.96

Sector

Healthcare

Industry

Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

Hidden in Plain Sight: 5 Best Stocks in Pharmaceuticals

Great opportunities to consider for the rest of 2015 and beyond.

The Zacks Analyst Blog Highlights: Conns, Valeant Pharmaceuticals, Trinseo, Nordic American Tankers

The Zacks Analyst Blog Highlights: Conns, Valeant Pharmaceuticals, Trinseo, Nordic American Tankers and Qiwi - Press Releases

Sears, Valeant Pharmaceuticals, Kinder Morgan: 3 Stocks Insiders Love

Does Valeant Have The Financial Flexibility To Acquire Zoetis?

AMAG Down on Cord Blood Registry Deal for $700 Million - Analyst Blog

BioMarin's NDA for DMD Drug Drisapersen Accepted by FDA - Analyst Blog

A Potential Valeant/Zoetis Merger

Regeneron/Bayer's Eylea Gets Label Expansion in Japan - Analyst Blog

Alexion's Strensiq and Kanuma Get Positive CHMP Opinions - Analyst Blog

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis

June 29 Premarket Biotech Digest: Trouble For Stryker Sub's Ex-CEO; Veracyte-Aetna Agreement; Zoetis Merger Rumors

See More VRX News...

VRX's Top Competitors

VRX $228.49 (0.11%)
Current stock: VRX
NVS $99.80 (1.30%)
Current stock: NVS
RHHBY $35.18 (0.10%)
Current stock: RHHBY
PFE $33.37 (-0.95%)
Current stock: PFE